ATE224896T1 - Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungen - Google Patents
Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungenInfo
- Publication number
- ATE224896T1 ATE224896T1 AT96202829T AT96202829T ATE224896T1 AT E224896 T1 ATE224896 T1 AT E224896T1 AT 96202829 T AT96202829 T AT 96202829T AT 96202829 T AT96202829 T AT 96202829T AT E224896 T1 ATE224896 T1 AT E224896T1
- Authority
- AT
- Austria
- Prior art keywords
- addition salt
- acid
- mixture
- enantiomer
- compound
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 7
- 239000002253 acid Substances 0.000 abstract 6
- 239000000203 mixture Substances 0.000 abstract 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000012452 mother liquor Substances 0.000 abstract 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 abstract 2
- -1 imidazolyl compound Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000000926 separation method Methods 0.000 abstract 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 abstract 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Epoxy Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95202765 | 1995-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE224896T1 true ATE224896T1 (de) | 2002-10-15 |
Family
ID=8220714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96202829T ATE224896T1 (de) | 1995-10-13 | 1996-10-10 | Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungen |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5663343A (de) |
| EP (1) | EP0768309B1 (de) |
| JP (2) | JP4590038B2 (de) |
| KR (1) | KR100459745B1 (de) |
| CN (1) | CN1060774C (de) |
| AT (1) | ATE224896T1 (de) |
| AU (1) | AU702594B2 (de) |
| CA (1) | CA2187484C (de) |
| CZ (1) | CZ288042B6 (de) |
| DE (1) | DE69623900T2 (de) |
| DK (1) | DK0768309T3 (de) |
| DZ (1) | DZ2104A1 (de) |
| ES (1) | ES2183908T3 (de) |
| HU (1) | HU226620B1 (de) |
| IL (1) | IL119400A (de) |
| NO (1) | NO307257B1 (de) |
| NZ (1) | NZ299562A (de) |
| PT (1) | PT768309E (de) |
| RU (1) | RU2162085C2 (de) |
| SK (1) | SK283471B6 (de) |
| TW (1) | TW513423B (de) |
| UA (1) | UA48947C2 (de) |
| ZA (1) | ZA968525B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19813661A1 (de) * | 1997-08-01 | 1999-02-04 | Solvay Pharm Gmbh | Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron |
| US6372919B1 (en) * | 2001-01-11 | 2002-04-16 | Dov Pharmaceutical, Inc. | (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
| RU2213562C2 (ru) * | 2001-03-14 | 2003-10-10 | Научно-исследовательский институт фармакологии РАМН | Лекарственная композиция |
| US20040048874A1 (en) * | 2001-05-22 | 2004-03-11 | Bardsley Hazel Judith | New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
| GB0216027D0 (en) * | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
| US7015333B2 (en) * | 2002-11-18 | 2006-03-21 | Solvay Pharmaceuticals B.V. | Process for preparation of imidazolyl compounds |
| EP1424337A1 (de) * | 2002-11-26 | 2004-06-02 | Solvay Pharmaceuticals GmbH | 4-Hydroxyderivate von 5,6,9,10-Tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-on |
| JP2006516976A (ja) * | 2003-01-13 | 2006-07-13 | ダイノゲン ファーマシューティカルズ,インコーポレイテッド | 機能性腸障害を処置する方法 |
| JP2006516977A (ja) * | 2003-01-13 | 2006-07-13 | ダイノゲン ファーマシューティカルズ,インコーポレイテッド | 悪心、嘔吐、レッチング、またはそれらの任意の組み合わせの治療方法 |
| EP1539181B1 (de) * | 2003-04-04 | 2007-06-27 | Dynogen Pharmaceuticals Inc. | Methode zur behandlung von erkrankungen der unteren harnwege |
| US20090018351A1 (en) * | 2003-11-12 | 2009-01-15 | Dr. Reddy's Laboratories, Inc. | Preparation of escitalopram |
| US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
| US20080045725A1 (en) | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
| US7601856B2 (en) | 2006-07-27 | 2009-10-13 | Wyeth | Benzofurans as potassium ion channel modulators |
| US7662831B2 (en) | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
| JP5156222B2 (ja) * | 2006-11-28 | 2013-03-06 | エムキュア ファーマシューティカルズ リミテッド | 制吐作用化合物の新たな製造方法 |
| GB0910373D0 (en) * | 2009-06-16 | 2009-07-29 | Filtrona Int Ltd | Tabacco smoke filter |
| US9806720B1 (en) * | 2016-10-07 | 2017-10-31 | Analog Devices Global | Compound semiconductor based inverter |
| CN112424149B (zh) | 2018-05-18 | 2023-06-23 | 库拉肿瘤学公司 | 替吡法尼的合成 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7413843A (nl) * | 1974-10-23 | 1976-04-27 | Stamicarbon | Optische scheiding van fenylglycine-amide. |
| US4463176A (en) * | 1982-09-13 | 1984-07-31 | Mead Johnson & Company | Process for resolution of optical isomers |
| US4849527A (en) * | 1982-09-13 | 1989-07-18 | Bristol-Myers Company | Process for resolution of optical isomers |
| SE460359B (sv) * | 1984-01-25 | 1989-10-02 | Glaxo Group Ltd | 3-imidazolylmetyltetrahydrokarbazoloner, foerfarande foer framstaellning av dessa och en farmaceutisk komposition |
| DE3885357T2 (de) * | 1987-06-29 | 1994-03-24 | Duphar Int Res | Anellierte Indolderivate. |
| GB8812636D0 (en) * | 1988-05-27 | 1988-06-29 | Glaxo Group Ltd | Chemical compounds |
| US5049563A (en) * | 1988-07-07 | 1991-09-17 | Duphar International Research B.V. | Annelated indoleketones with an imidazolylalkyl substituent |
| DE4238553A1 (de) * | 1992-11-14 | 1994-05-19 | Kali Chemie Pharma Gmbh | Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel |
| RU2041876C1 (ru) * | 1993-12-29 | 1995-08-20 | Научно-производственный центр "Фармзащита" | Способ получения 1,2,3,9- тетрагидро-9-метил-3- [(2-метил-1н- имидазол-1-ил) метил]-4н- карбазол-4-она или его солей, или их гидратов, и промежуточные продукты для их синтеза |
-
1996
- 1996-09-26 AU AU65856/96A patent/AU702594B2/en not_active Ceased
- 1996-10-03 TW TW085112098A patent/TW513423B/zh not_active IP Right Cessation
- 1996-10-08 JP JP28461296A patent/JP4590038B2/ja not_active Expired - Fee Related
- 1996-10-08 SK SK1287-96A patent/SK283471B6/sk not_active IP Right Cessation
- 1996-10-08 CZ CZ19962947A patent/CZ288042B6/cs not_active IP Right Cessation
- 1996-10-09 CA CA002187484A patent/CA2187484C/en not_active Expired - Fee Related
- 1996-10-09 DZ DZ960148A patent/DZ2104A1/fr active
- 1996-10-09 ZA ZA968525A patent/ZA968525B/xx unknown
- 1996-10-09 RU RU96120366/04A patent/RU2162085C2/ru not_active IP Right Cessation
- 1996-10-09 NO NO964282A patent/NO307257B1/no not_active IP Right Cessation
- 1996-10-09 HU HU9602778A patent/HU226620B1/hu not_active IP Right Cessation
- 1996-10-10 UA UA96103876A patent/UA48947C2/uk unknown
- 1996-10-10 IL IL11940096A patent/IL119400A/xx not_active IP Right Cessation
- 1996-10-10 CN CN96122637A patent/CN1060774C/zh not_active Expired - Fee Related
- 1996-10-10 PT PT96202829T patent/PT768309E/pt unknown
- 1996-10-10 AT AT96202829T patent/ATE224896T1/de active
- 1996-10-10 EP EP96202829A patent/EP0768309B1/de not_active Expired - Lifetime
- 1996-10-10 DK DK96202829T patent/DK0768309T3/da active
- 1996-10-10 DE DE69623900T patent/DE69623900T2/de not_active Expired - Lifetime
- 1996-10-10 US US08/728,794 patent/US5663343A/en not_active Expired - Lifetime
- 1996-10-10 ES ES96202829T patent/ES2183908T3/es not_active Expired - Lifetime
- 1996-10-10 KR KR1019960044972A patent/KR100459745B1/ko not_active Expired - Fee Related
- 1996-10-11 NZ NZ299562A patent/NZ299562A/en not_active IP Right Cessation
-
2010
- 2010-04-15 JP JP2010094211A patent/JP2010159292A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE224896T1 (de) | Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungen | |
| US5281722A (en) | Preparation and use of salts of the pure enantiomers of alpha-lipoic acid | |
| FI110776B (fi) | Menetelmä substituoitujen fenyylipropionihappojen oleellisesti puhtaiden enantiomeerien valmistamiseksi | |
| RU96120366A (ru) | Способ получения энантиомерно чистых соединений имидазолила, энантиомерно чистая кислая аддитивная соль имидазолила и в-пироглутаминовой кислоты | |
| FI117438B (fi) | Menetelmä optisesti rikastetun bupivakaiinin valmistamiseksi | |
| JP4015696B2 (ja) | レボブピバカインと同類のピペリジンカルボキサニリド麻酔剤の製造に用いるラセミ化法 | |
| RU94046047A (ru) | Производные аминоуксусной кислоты в виде рацемата или d- и l-энантиомеров и их фармацевтически приемлемые соли, способ получения d- и l-энантиомеров производных аминоуксусной кислоты или их фармацевтически приемлемых солей и промежуточные d- и l-энантиомеры аминоуксусной кислоты в виде цинхонидиновой соли | |
| EP0220435B1 (de) | Verfahren zur Herstellung optisch aktiver Halbester | |
| ATE118476T1 (de) | Verfahren zur herstellung von l-carnitin aus d,l- carnitinnitrilsalzen. | |
| SK140898A3 (en) | Improved process for the production of enantiomerically-pure azetidine-2-carboxylic acid | |
| EP0970049B1 (de) | Verfahren zur herstellung von enantiomerisch angereicherten n-acylazetidin-2-carbonsäuren | |
| KR940002220A (ko) | 광학활성 메티오닌아미드를 제조하는 방법 | |
| PL343556A1 (en) | Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide | |
| JPS6323824A (ja) | 酸性α−水素を有するアミンの光学分割およびラセミ化方法 | |
| JPH10506384A (ja) | 二環式ラクタム鏡像体の分離法 | |
| Schjelderup et al. | The absolute configuration of oxyphencyclimine, a parasympatholytic drug. Syntheses of both enantiomers | |
| US4584313A (en) | (Substituted-phenyl)-5-oxo-2-pyrrolidinepropanoic acids and esters thereof, and use for reversing electroconvulsive shock-induced amnesia | |
| HU205594B (en) | Process for producing optical isomeres of cyclopropane-carboxylic acids5 | |
| ATE212615T1 (de) | Verfahren zur herstellung von (1s,2r)-1-amino-2- indanol-(r,r)-tartrate methanol solvat | |
| DK0556909T3 (da) | Fremgangsmåde til fremstilling af (R) - og (S) - 1,2-isopropylildenglycol | |
| WO1990002118A1 (en) | Derivatives and precursors of captopril and its analogues | |
| RU96118236A (ru) | 8-галоген-6-гидроксиоктановые кислоты, их эфиры, соли, способы их получения и применение | |
| WO1990002732A1 (en) | Methods for preparing captopril and its analogues | |
| ATE198189T1 (de) | Synthese von optisch aktivem aminoindanol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner |